Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1

Immunology Letters

Volumn 127, Issue 2, 2010, Pages 108-118

  Kovács Sólyom, Ferenc ^a   Blaskó, Andrea ^a   Fajka Boja, Roberta ^a   Katona, Róbert L ^a   Végh, Lea ^a   Novák, Julianna ^a   Szebeni, Gábor János ^a   Krenács, László ^b   Uher, Ferenc ^c   Tubak, Vilmos ^a   Kiss, Robert ^d   Monostori, Éva ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b Laboratory of Tumor Pathology and Molecular Diagnostics   (Hungary)

^c National Blood Center   (Hungary)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Galectin 1; T cell apoptosis; Tumor cells; Tumor associated stroma cells

Indexed keywords

CASPASE; GALECTIN 1; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70;

APOPTOSIS; ARTICLE; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FEMALE; FIBROBLAST; GLIOBLASTOMA; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MELANOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DYNAMICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH;

APOPTOSIS; CASPASES; CELL COMMUNICATION; COCULTURE TECHNIQUES; DISEASE PROGRESSION; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEOPLASM PROTEINS; NEOPLASMS; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRANSGENES; TUMOR ESCAPE; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 71649092570     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.10.003     Document Type: Article

References (44)

1. Camby I., Le Mercier M., Lefranc F., and Kiss R. Galectin-1: a small protein with major functions. Glycobiology 16 (2006) 137R-157R
2. Jung E.J., Moon H.G., Cho B.I., Jeong C.Y., Joo Y.T., Lee Y.J., et al. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 120 (2007) 2331-2338
3. Camby I., Belot N., Lefranc F., Sadeghi N., de Launoit Y., Kaltner H., et al. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61 (2002) 585-596
4. Le Mercier M., Mathieu V., Haibe-Kains B., Bontempi G., Mijatovic T., Decaestecker C., et al. Knocking down galectin-1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. J Neuropathol Exp Neurol 67 (2008) 456-469
5. Le Q.T., Shi G., Cao H., Nelson D.W., Wang Y., Chen E.Y., et al. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23 (2005) 8932-8941
6. Thijssen V.L., Postel R., Brandwijk R.J., Dings R.P., Nesmelova I., Satijn S., et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103 (2006) 15975-15980
7. Moiseeva E.P., Javed Q., Spring E.L., and de Bono D.P. Galectin-1 is involved in vascular smooth muscle cell proliferation. Cardiovasc Res 45 (2000) 493-502
8. Rabinovich G.A., Gabrilovich D., and Sotomayor E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25 (2007) 267-296
9. Rubinstein N., Alvarez M., Zwirner N.W., Toscano M.A., Ilarregui J.M., Bravo A., et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor-immune privilege. Cancer Cell 5 (2004) 241-251
10. Mathieu V., Le Mercier M., De Neve N., Sauvage S., Gras T., Roland I., et al. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol 127 (2007) 2399-2410
11. Daroqui C.M., Ilarregui J.M., Rubinstein N., Salatino M., Toscano M.A., Vazquez P., et al. Regulation of galectin-1 expression by transforming growth factor β1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape. Cancer Immunol Immunother 56 (2007) 491-499
12. van der L.J., van den B.A., Harms G., Eschbach H., Vos H., Zwiers P., et al. Strongly enhanced IL-10 production using stable galectin-1 homodimers. Mol Immunol 44 (2007) 506-513
13. + T cells. Blood 109 (2007) 2058-2065
14. Orentas R.J., Kohler M.E., and Johnson B.D. Suppression of anti-cancer immunity by regulatory T cells: back to the future. Semin Cancer Biol 16 (2006) 137-149
15. Cooper D., Norling L.V., and Perretti M. Novel insights into the inhibitory effects of galectin-1 on neutrophil recruitment under flow. J Leukoc Biol 83 (2008) 1459-1466
16. Norling L.V., Sampaio A.L., Cooper D., and Perretti M. Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking. FASEB J 22 (2008) 682-690
17. Gandhi M.K., Moll G., Smith C., Dua U., Lambley E., Ramuz O., et al. Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. Blood 110 (2007) 1326-1329
18. Juszczynski P., Ouyang J., Monti S., Rodig S.J., Takeyama K., Abramson J., et al. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci USA 104 (2007) 13134-13139
19. lck and ZAP70-mediated tyrosine phosphorylation in galectin-1-induced cell death. Cell Death Differ 12 (2005) 1145-1147
20. Ion G., Fajka-Boja R., Kovacs F., Szebeni G., Gombos I., Czibula A., et al. Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1. Cell Signal 18 (2006) 1887-1896
21. Matarrese P., Tinari A., Mormone E., Bianco G.A., Toscano M.A., Ascione B., et al. Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J Biol Chem 280 (2005) 6969-6985
22. Sturm A., Lensch M., Andre S., Kaltner H., Wiedenmann B., Rosewicz S., et al. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 173 (2004) 3825-3837
23. Brandt B., Buchse T., Abou-Eladab E.F., Tiedge M., Krause E., Jeschke U., et al. Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes. Histochem Cell Biol 129 (2008) 599-609
24. Hahn H.P., Pang M., He J., Hernandez J.D., Yang R.Y., Li L.Y., et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ 11 (2004) 1277-1286
25. Stowell S.R., Qian Y., Karmakar S., Koyama N.S., Dias-Baruffi M., Leffler H., et al. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 180 (2008) 3091-3102
26. Straus D.B., and Weiss A. Genetic evidence for the involvement of the Lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70 (1992) 585-593
27. Williams B.L., Schreiber K.L., Zhang W., Wange R.L., Samelson L.E., Leibson P.J., et al. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol Cell Biol 18 (1998) 1388-1399
28. Fajka-Boja R., Szemes M., Ion G., Legradi A., Caron M., and Monostori E. Receptor tyrosine phosphatase, CD45 binds galectin-1 but does not mediate its apoptotic signal in T cell lines. Immunol Lett 82 (2002) 149-154
29. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139 (1991) 271-279
30. Hirabayashi J., Ayaki H., Soma G., and Kasai K. Cloning and nucleotide sequence of a full-length cDNA for human 14 kDa β-galactoside-binding lectin. Biochim Biophys Acta 1008 (1989) 85-91
31. Fajka-Boja R., Blaskó A., Kovács-Sólyom F., Szebeni G.J., Tóth G.K., and Monostori E. Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin- and raft-dependent endocytosis. Cell Mol Life Sci 65 (2008) 2586-2593
32. Kiss J., Kunstar A., Fajka-Boja R., Dudics V., Tovari J., Legradi A., et al. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization. Exp Hematol 35 (2007) 305-313
33. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190 (1999) 385-398
34. Rabinovich G.A., Liu F.T., Hirashima M., and Anderson A. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol 66 (2007) 143-158
35. Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., et al. Differential glycosylation of TH1, TH2 and TH17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8 (2007) 825-834
36. He J., and Baum L.G. Presentation of galectin-1 by extracellular matrix triggers T cell death. J Biol Chem 279 (2004) 4705-4712
37. Santucci L., Fiorucci S., Rubinstein N., Mencarelli A., Palazzetti B., Federici B., et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124 (2003) 1381-1394
38. Saussez S., Lorfevre F., Lequeux T., Laurent G., Chantrain G., Vertongen F., et al. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral Oncol 44 (2008) 86-93
39. Jung T.Y., Jung S., Ryu H.H., Jeong Y.I., Jin Y.H., Jin S.G., et al. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines. J Neurosurg 109 (2008) 273-284
40. Saussez S., Decaestecker C., Lorfevre F., Cucu D.R., Mortuaire G., Chevalier D., et al. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. Int J Oncol 30 (2007) 1109-1117
41. Saussez S., Camby I., Toubeau G., and Kiss R. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head Neck 29 (2007) 874-884
42. He J., and Baum L.G. Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Lab Invest 86 (2006) 578-590
43. Thijssen V.L., Hulsmans S., and Griffioen A.W. The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol 172 (2008) 545-553
44. Valenzuela H.F., Pace K.E., Cabrera P.V., White R., Porvari K., Kaija H., et al. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. Cancer Res 67 (2007) 6155-6162